Medical News

RSS

‘Window for intervention’ to forestall hypertensive cognitive decline

Newly diagnosed hypertension is predictive of cognitive decline in middle-aged individuals and is worse in those with poorly controlled blood pressure, Dutch researchers have found.

16 Dec 2013

Interactive booklet boosts parents’ RTI confidence

An interactive booklet given to parents in primary care can help them to be more knowledgeable and feel more confident about when and when not to consult a doctor for their child’s respiratory tract infections.

16 Dec 2013

New Opterra multipoint scanning confocal microscope from Bruker

Today at the 2013 American Society for Cell Biology Annual Meeting, Bruker introduced the Opterra Multipoint Scanning Confocal Microscope, which sets a new standard for integration of confocal imaging with photoactivation.

16 Dec 2013

Bay Area Lyme Foundation announces Emerging Leader Award for promising scientist in Lyme research

The Bay Area Lyme Foundation today announced the first annual Bay Area Lyme Foundation 'Emerging Leader Award' and a $100,000 grant which will be given to a promising scientist who embodies the future of leadership in Lyme disease research.

16 Dec 2013

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).

16 Dec 2013

Medical Daily announces marketing and distribution partnership with UBM Medica US

Medical Daily announced today a unique marketing and distribution partnership with UBM Medica US. Medical Daily is a source of breaking health news, scientific trends and innovations.

16 Dec 2013

MicroBiome Therapeutics announces completion of $1.3M bridge financing

MicroBiome TherapeuticsTM LLC, today announced completion of a $1.3 million bridge financing. It is intended to support completion of the company's two ongoing clinical studies and preparations for further clinical trials of lead product NM504, a microbiome modulator in development for type 2 diabetes and prediabetes. The bridge financing was led by current investor BVM Capital, who was joined in the round by other existing MBT investors.

16 Dec 2013

TELUS Health to offer Medworxx Patient Flow Platform to customers

Medworxx Solutions Inc. today announced that TELUS Health will now offer customers the Medworxx Patient Flow Platform, enabling health care practitioners to better analyze and monitor patient health in an acute care environment. Comprised of Medworxx Clinical Criteria, Bed Management System, and Forms and Assessments, the platform is available as part of TELUS Health's suite of technology solutions.

16 Dec 2013

Glioblastoma multiforme patients treated with experimental vaccine show improved survival

Patients with recurrent glioblastoma multiforme treated with an experimental vaccine made from the patient's own resected tumor tissue showed an improved survival compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine that was recently published in the journal Neuro-Oncology and accompanied by an editorial highlighting the importance of the trial.

16 Dec 2013

First Edition: December 16, 2013

Today's headlines include findings from an Associated Press poll probing Americans thoughts about the health law.

16 Dec 2013

Two UTHealth professors elected fellows of American Association for the Advancement of Science

Two professors at The University of Texas Health Science Center at Houston - Barry Davis, M.D., Ph.D., and Kevin Morano, Ph.D. - have been elected fellows into the American Association for the Advancement of Science, the world's largest general scientific society and publisher of the journal Science.

16 Dec 2013

Better to fat finger a text than to lose a finger due to the cold

The popular half-gloves that leave fingers uncovered for texting may be good for communicating electronically but they may also lead to permanent loss of fingers due to exposure to the cold. "Fingers are one of the first body parts to feel the effects of the cold and damp and along with toes, ears and the nose are frequently subjected to frostbite and even amputation," says Arthur Sanford, MD, Division of Trauma, Surgical Critical Care and Burns, Loyola University Health System.

16 Dec 2013

Experimental drug that targets macrophages decreases cancer's growth

An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology annual meeting in New Orleans.

16 Dec 2013

Queen's University professor wins Gold Award for Innovation for research on male infertility

A Queen's University Professor has received international recognition for her research into male infertility.

16 Dec 2013

OncoSec Medical reports positive interim data from OMS-I100 Phase 2 trial for metastatic melanoma

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced positive interim data from its ongoing Phase 2 trial of OMS-I100 in the treatment of metastatic melanoma. The results were presented by principal investigator Adil Daud, MD, at the Advances in Cancer Immunotherapy meeting at the University of California San Francisco.

16 Dec 2013

New classification system to manage emergency surgery described in special issue of BJS

Researchers in Finland have implemented a classification system for emergency operations that allows for a fair and efficient way to manage a large volume of such surgery.

16 Dec 2013

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

Stem cells have a potential to develop into multiple cell types and divide without limit to replenish cells in human body throughout the life of individual.

16 Dec 2013

NYSE publicly traded industry selects EPGL's advanced technologies for development

EP Global Communications, Inc., makes the following announcement: In a first for the company, one of EPGL's advanced technologies has been selected by a multi-billion dollar, NYSE publicly traded industry leader for development and integration into new products.

16 Dec 2013

Data show that HCV genotype-1 infected patients may benefit from faldaprevir

Data show that Boehringer Ingelheim’s second-generation protease inhibitor faldaprevir, when used in combination with pegylated interferon and ribavirin, was effective even with the presence of naturally-occurring mutant variants of the hepatitis C virus, such as the NS3 Q80K polymorphism

16 Dec 2013

State highlights: Fewer visits to Texas women's clinics after planned parenthood exclusion; Minn. health spending growth slows

To stop Planned Parenthood clinics from receiving public financing, Texas' Republican leaders gambled that the state could operate a contraception and cancer-screening program for low-income women without tens of millions of federal dollars. But with the exclusion of about 40 Planned Parenthood clinics -- none of which performed abortions -- from the Texas Women's Health Program in 2013, records showed that claims for birth control and wellness exams dropped, as did enrollment numbers (Aaronson, 12/12).

16 Dec 2013

Medical News

‘Window for intervention’ to forestall hypertensive cognitive decline

Interactive booklet boosts parents’ RTI confidence

New Opterra multipoint scanning confocal microscope from Bruker

Bay Area Lyme Foundation announces Emerging Leader Award for promising scientist in Lyme research

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

Medical Daily announces marketing and distribution partnership with UBM Medica US

MicroBiome Therapeutics announces completion of $1.3M bridge financing

TELUS Health to offer Medworxx Patient Flow Platform to customers

Glioblastoma multiforme patients treated with experimental vaccine show improved survival

First Edition: December 16, 2013

Two UTHealth professors elected fellows of American Association for the Advancement of Science

Better to fat finger a text than to lose a finger due to the cold

Experimental drug that targets macrophages decreases cancer's growth

Queen's University professor wins Gold Award for Innovation for research on male infertility

OncoSec Medical reports positive interim data from OMS-I100 Phase 2 trial for metastatic melanoma

New classification system to manage emergency surgery described in special issue of BJS

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

NYSE publicly traded industry selects EPGL's advanced technologies for development

Data show that HCV genotype-1 infected patients may benefit from faldaprevir

State highlights: Fewer visits to Texas women's clinics after planned parenthood exclusion; Minn. health spending growth slows

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News